2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 97%, 1g

1,2,3,4-Tetrahydro-1,6-naphthyridine, 95.0%, 500mg

tri-Natriumcitrat-Dihydrat, min. 99 % Ph.Eur., 500 g, kunststoffverpackung.

1,1,1-TRICHLORO-4-ETHOXY-BUT-3-EN-2-ONE, 95.0%, 5g

1,1-Dimethylpiperidin-1-ium-4-yl octadecyl phosphate, 95.0%, 100mg

h-ala-obzl.tosoh, 98.0%, 500g

1,2-Bis(tert-butoxycarbonyl)hexahydropyridazine-3-carboxylic acid, 98%, 250mg

ethyl 5-iodo-1H-imidazole-2-carboxylate, 97%, 250mg

1,3-Di-tert-butyl-5-ethyl-5-nitro-1,3-diazinane, 250mg

5 mm NMR Economy Sample Tube, 8" L, 100 MHz, 5x1ea

2,3-Dihydroxypropyl butyrate, 97%, 1g

tert-butyl [(3Z)-3-amino-3-(hydroxyimino)propyl]carbamate, 95.0%, 1g

(S)-2-Amino-4-((4-chlorobenzyl)amino)-1-(piperidin-1-yl)butan-1-one dihydrochloride, 98%, 250mg